Market Intelligence chevron_right Pharma & Healthcare chevron_right Influenza Virus Vaccine (H1N1)
Global Report 2021

Global Influenza Virus Vaccine (H1N1) Sales Market Report 2024

calendar_todayPublished: Nov 2021 descriptionPages: 149 categoryCategory: Pharma & Healthcare
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Influenza Virus Vaccine (H1N1) Market Overview
    1.1 Influenza Virus Vaccine (H1N1) Product Scope
    1.2 Influenza Virus Vaccine (H1N1) Segment by Type
        1.2.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016 & 2021 & 2027)
        1.2.2 Intramuscular Vaccine
        1.2.3 Nasal Spray Vaccine
    1.3 Influenza Virus Vaccine (H1N1) Segment by Application
        1.3.1 Global Influenza Virus Vaccine (H1N1) Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 3 To 10 Years Old
        1.3.3 10 To 18 Years Old
        1.3.4 Above 18 Years Old
        1.3.5 Other
    1.4 Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Influenza Virus Vaccine (H1N1) Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Influenza Virus Vaccine (H1N1) Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Influenza Virus Vaccine (H1N1) Price Trends (2016-2027)

2 Influenza Virus Vaccine (H1N1) Estimates and Forecasts by Region
    2.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
        2.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2021)
    2.3 Global Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
        2.4.2 Europe Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
        2.4.3 China Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
        2.4.4 Japan Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
        2.4.6 India Influenza Virus Vaccine (H1N1) Estimates and Projections (2016-2027)
3 Global Influenza Virus Vaccine (H1N1) Competition Landscape by Players
    3.1 Global Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021)
    3.2 Global Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021)
    3.3 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020)
    3.4 Global Influenza Virus Vaccine (H1N1) Average Price by Company (2016-2021)
    3.5 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Influenza Virus Vaccine (H1N1) Market Size by Type
    4.1 Global Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021)
        4.1.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
        4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
        4.1.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2021)
    4.2 Global Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
        4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
        4.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027)
5 Global Influenza Virus Vaccine (H1N1) Market Size by Application
    5.1 Global Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021)
        5.1.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
        5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
        5.1.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
    5.2 Global Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
        5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
        5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)

6 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures
    6.1 North America Influenza Virus Vaccine (H1N1) Sales by Company
        6.1.1 North America Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
        6.1.2 North America Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
    6.2 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
        6.2.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        6.2.2 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
    6.3 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
        6.3.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
        6.3.2 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2022-2027)

7 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures
    7.1 Europe Influenza Virus Vaccine (H1N1) Sales by Company
        7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
        7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
    7.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
        7.2.1 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
    7.3 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
        7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Influenza Virus Vaccine (H1N1) Market Facts & Figures
    8.1 China Influenza Virus Vaccine (H1N1) Sales by Company
        8.1.1 China Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
        8.1.2 China Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
    8.2 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
        8.2.1 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        8.2.2 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
    8.3 China Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
        8.3.1 China 314 Sales Breakdown by Application (2016-2021)
        8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Influenza Virus Vaccine (H1N1) Market Facts & Figures
    9.1 Japan Influenza Virus Vaccine (H1N1) Sales by Company
        9.1.1 Japan Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
        9.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
    9.2 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
        9.2.1 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
    9.3 Japan Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Influenza Virus Vaccine (H1N1) Market Facts & Figures
    10.1 Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Company
        10.1.1 Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
        10.1.2 Southeast Asia Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
    10.2 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
        10.2.1 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
        10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Influenza Virus Vaccine (H1N1) Market Facts & Figures
    11.1 India Influenza Virus Vaccine (H1N1) Sales by Company
        11.1.1 India Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021)
        11.1.2 India Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021)
    11.2 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Type
        11.2.1 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021)
        11.2.2 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2022-2027)
    11.3 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Application
        11.3.1 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021)
        11.3.2 India Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business
    12.1 CSL
        12.1.1 CSL Corporation Information
        12.1.2 CSL Business Overview
        12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
        12.1.5 CSL Recent Development
    12.2 NVS(Novartis)
        12.2.1 NVS(Novartis) Corporation Information
        12.2.2 NVS(Novartis) Business Overview
        12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered
        12.2.5 NVS(Novartis) Recent Development
    12.3 Sanofi Pasteur
        12.3.1 Sanofi Pasteur Corporation Information
        12.3.2 Sanofi Pasteur Business Overview
        12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered
        12.3.5 Sanofi Pasteur Recent Development
    12.4 Medimmune
        12.4.1 Medimmune Corporation Information
        12.4.2 Medimmune Business Overview
        12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered
        12.4.5 Medimmune Recent Development
    12.5 GSK
        12.5.1 GSK Corporation Information
        12.5.2 GSK Business Overview
        12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered
        12.5.5 GSK Recent Development
    12.6 Baxter
        12.6.1 Baxter Corporation Information
        12.6.2 Baxter Business Overview
        12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered
        12.6.5 Baxter Recent Development
    12.7 Beijing Kexing Bio-Vaccine
        12.7.1 Beijing Kexing Bio-Vaccine Corporation Information
        12.7.2 Beijing Kexing Bio-Vaccine Business Overview
        12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
        12.7.5 Beijing Kexing Bio-Vaccine Recent Development
    12.8 Hualan Bio-Vaccine
        12.8.1 Hualan Bio-Vaccine Corporation Information
        12.8.2 Hualan Bio-Vaccine Business Overview
        12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
        12.8.5 Hualan Bio-Vaccine Recent Development
    12.9 Changchun Changsheng Bio-Technology
        12.9.1 Changchun Changsheng Bio-Technology Corporation Information
        12.9.2 Changchun Changsheng Bio-Technology Business Overview
        12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
        12.9.5 Changchun Changsheng Bio-Technology Recent Development
    12.10 Beijing Tiantan Bio-Products
        12.10.1 Beijing Tiantan Bio-Products Corporation Information
        12.10.2 Beijing Tiantan Bio-Products Business Overview
        12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered
        12.10.5 Beijing Tiantan Bio-Products Recent Development
    12.11 Jiangsu Yanshen Bio-Technology
        12.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
        12.11.2 Jiangsu Yanshen Bio-Technology Business Overview
        12.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
        12.11.5 Jiangsu Yanshen Bio-Technology Recent Development
    12.12 Zhejiang Tianyuan Bio-Pharmaceutical
        12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
        12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
        12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered
        12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
    12.13 Dalian Yalifeng Bio-Pharmaceutical
        12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
        12.13.2 Dalian Yalifeng Bio-Pharmaceutical Business Overview
        12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered
        12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
    12.14 Sinopharm
        12.14.1 Sinopharm Corporation Information
        12.14.2 Sinopharm Business Overview
        12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        12.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Products Offered
        12.14.5 Sinopharm Recent Development

13 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis
    13.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
    13.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Influenza Virus Vaccine (H1N1) Distributors List
    14.3 Influenza Virus Vaccine (H1N1) Customers

15 Market Dynamics
    15.1 Influenza Virus Vaccine (H1N1) Market Trends
    15.2 Influenza Virus Vaccine (H1N1) Drivers
    15.3 Influenza Virus Vaccine (H1N1) Market Challenges
    15.4 Influenza Virus Vaccine (H1N1) Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Influenza Virus Vaccine (H1N1) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Influenza Virus Vaccine (H1N1) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Influenza Virus Vaccine (H1N1) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Region (2016-2021)
    Table 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
    Table 6. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Influenza Virus Vaccine (H1N1) Revenue Share by Region (2016-2021)
    Table 8. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Forecast by Region (2022-2027)
    Table 9. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Influenza Virus Vaccine (H1N1) Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) of Key Companies (2016-2021)
    Table 13. Global Influenza Virus Vaccine (H1N1) Sales Share by Company (2016-2021)
    Table 14. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Influenza Virus Vaccine (H1N1) Revenue Share by Company (2016-2021)
    Table 16. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020)
    Table 17. Global Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Company (2016-2021)
    Table 18. Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites and Area Served
    Table 19. Manufacturers Influenza Virus Vaccine (H1N1) Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
    Table 22. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2016-2021)
    Table 23. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2016-2021)
    Table 25. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2022-2027)
    Table 26. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2022-2027)
    Table 28. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2022-2027)
    Table 29. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2016-2021) 
    Table 30. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2016-2021)
    Table 31. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2016-2021)
    Table 33. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2022-2027)
    Table 34. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2022-2027)
    Table 35. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2022-2027)
    Table 37. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2022-2027)
    Table 38. North America Influenza Virus Vaccine (H1N1) Sales (K Doses) by Company (2016-2021)
    Table 39. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2016-2021)
    Table 40. North America Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2016-2021)
    Table 42. North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 43. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 44. North America Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 45. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2022-2027)
    Table 46. North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 47. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 48. North America Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 49. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022-2027)
    Table 50. Europe Influenza Virus Vaccine (H1N1) Sales (K Doses) by Company (2016-2021)
    Table 51. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2016-2021)
    Table 52. Europe Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2016-2021)
    Table 54. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 55. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 56. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 57. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2022-2027)
    Table 58. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 59. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 60. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 61. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022-2027)
    Table 62. China Influenza Virus Vaccine (H1N1) Sales (K Doses) by Company (2016-2021)
    Table 63. China Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2016-2021)
    Table 64. China Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2016-2021)
    Table 66. China Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 67. China Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 68. China Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 69. China Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2022-2027)
    Table 70. China Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 71. China Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 72. China Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 73. China Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022-2027)
    Table 74. Japan Influenza Virus Vaccine (H1N1) Sales (K Doses) by Company (2016-2021)
    Table 75. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2016-2021)
    Table 76. Japan Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2016-2021)
    Table 78. Japan Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 79. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 80. Japan Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 81. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2022-2027)
    Table 82. Japan Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 83. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 84. Japan Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 85. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Influenza Virus Vaccine (H1N1) Sales (K Doses) by Company (2016-2021)
    Table 87. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 91. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 93. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 95. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 97. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022-2027)
    Table 98. India Influenza Virus Vaccine (H1N1) Sales (K Doses) by Company (2016-2021)
    Table 99. India Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2016-2021)
    Table 100. India Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2016-2021)
    Table 102. India Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses)
    Table 103. India Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 104. India Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses)
    Table 105. India Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2022-2027)
    Table 106. India Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses)
    Table 107. India Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 108. India Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses)
    Table 109. India Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2022-2027)
    Table 110. CSL Corporation Information
    Table 111. CSL Description and Business Overview
    Table 112. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 113. CSL Influenza Virus Vaccine (H1N1) Product
    Table 114. CSL Recent Development
    Table 115. NVS(Novartis) Corporation Information
    Table 116. NVS(Novartis) Description and Business Overview
    Table 117. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 118. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product
    Table 119. NVS(Novartis) Recent Development
    Table 120. Sanofi Pasteur Corporation Information
    Table 121. Sanofi Pasteur Description and Business Overview
    Table 122. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 123. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product
    Table 124. Sanofi Pasteur Recent Development
    Table 125. Medimmune Corporation Information
    Table 126. Medimmune Description and Business Overview
    Table 127. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 128. Medimmune Influenza Virus Vaccine (H1N1) Product
    Table 129. Medimmune Recent Development
    Table 130. GSK Corporation Information
    Table 131. GSK Description and Business Overview
    Table 132. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 133. GSK Influenza Virus Vaccine (H1N1) Product
    Table 134. GSK Recent Development
    Table 135. Baxter Corporation Information
    Table 136. Baxter Description and Business Overview
    Table 137. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 138. Baxter Influenza Virus Vaccine (H1N1) Product
    Table 139. Baxter Recent Development
    Table 140. Beijing Kexing Bio-Vaccine Corporation Information
    Table 141. Beijing Kexing Bio-Vaccine Description and Business Overview
    Table 142. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 143. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
    Table 144. Beijing Kexing Bio-Vaccine Recent Development
    Table 145. Hualan Bio-Vaccine Corporation Information
    Table 146. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 147. Hualan Bio-Vaccine Description and Business Overview
    Table 148. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
    Table 149. Hualan Bio-Vaccine Recent Development
    Table 150. Changchun Changsheng Bio-Technology Corporation Information
    Table 151. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 152. Changchun Changsheng Bio-Technology Description and Business Overview
    Table 153. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product
    Table 154. Changchun Changsheng Bio-Technology Recent Development
    Table 155. Beijing Tiantan Bio-Products Corporation Information
    Table 156. Beijing Tiantan Bio-Products Description and Business Overview
    Table 157. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 158. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product
    Table 159. Beijing Tiantan Bio-Products Recent Development
    Table 160. Jiangsu Yanshen Bio-Technology Corporation Information
    Table 161. Jiangsu Yanshen Bio-Technology Description and Business Overview
    Table 162. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 163. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product
    Table 164. Jiangsu Yanshen Bio-Technology Recent Development
    Table 165. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
    Table 166. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
    Table 167. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 168. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
    Table 169. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
    Table 170. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
    Table 171. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
    Table 172. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 173. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
    Table 174. Dalian Yalifeng Bio-Pharmaceutical Recent Development
    Table 175. Sinopharm Corporation Information
    Table 176. Sinopharm Description and Business Overview
    Table 177. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 178. Sinopharm Influenza Virus Vaccine (H1N1) Product
    Table 179. Sinopharm Recent Development
    Table 180. Production Base and Market Concentration Rate of Raw Material
    Table 181. Key Suppliers of Raw Materials
    Table 182. Influenza Virus Vaccine (H1N1) Distributors List
    Table 183. Influenza Virus Vaccine (H1N1) Customers List
    Table 184. Influenza Virus Vaccine (H1N1) Market Trends
    Table 185. Influenza Virus Vaccine (H1N1) Market Drivers
    Table 186. Influenza Virus Vaccine (H1N1) Market Challenges
    Table 187. Influenza Virus Vaccine (H1N1) Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Virus Vaccine (H1N1) Product Picture
    Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2021 & 2027
    Figure 6. 3 To 10 Years Old Examples
    Figure 7. 10 To 18 Years Old Examples
    Figure 8. Above 18 Years Old Examples
    Figure 9. Other Examples
    Figure 10. Global Influenza Virus Vaccine (H1N1) Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 12. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Growth Rate (2016-2027)
    Figure 13. Global Influenza Virus Vaccine (H1N1) Price Trends Growth Rate (2016-2027) (US$/Dose)
    Figure 14. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region: 2016 VS 2021
    Figure 15. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region: 2021 VS 2027
    Figure 16. North America Influenza Virus Vaccine (H1N1) Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. North America Influenza Virus Vaccine (H1N1) Sales (K Doses) Growth Rate (2016-2027)
    Figure 18. Europe Influenza Virus Vaccine (H1N1) Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. Europe Influenza Virus Vaccine (H1N1) Sales (Million USD) Growth Rate (2016-2027)
    Figure 20. China Influenza Virus Vaccine (H1N1) Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. China Influenza Virus Vaccine (H1N1) Sales (Million USD) and Growth Rate (2016-2027)
    Figure 22. Japan Influenza Virus Vaccine (H1N1) Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Japan Influenza Virus Vaccine (H1N1) Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Southeast Asia Influenza Virus Vaccine (H1N1) Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. India Influenza Virus Vaccine (H1N1) Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. India Influenza Virus Vaccine (H1N1) Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. Global 5 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue in Influenza Virus Vaccine (H1N1): 2016 & 2020
    Figure 29. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 30. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2016-2021)
    Figure 31. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate by Type in 2016 & 2020
    Figure 32. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2016-2021)
    Figure 33. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate by Application in 2016 & 2020
    Figure 34. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
    Figure 35. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
    Figure 36. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
    Figure 37. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
    Figure 38. China Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
    Figure 39. China Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
    Figure 40. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
    Figure 41. Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
    Figure 42. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
    Figure 43. Southeast Asia Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
    Figure 44. India Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
    Figure 45. India Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
    Figure 46. Key Raw Materials Price Trend
    Figure 47. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1) 
    Figure 48. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
    Figure 49. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation 
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm

Frequently Asked Questions

What is the USP of the report? expand_more
Influenza Virus Vaccine (H1N1) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Influenza Virus Vaccine (H1N1) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Influenza Virus Vaccine (H1N1) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.